164 related articles for article (PubMed ID: 35389164)
21. Expression of Mucin 1 in salivary gland tumors and its correlation with clinicopathological factors.
Ma S; An F; Li LH; Lin YY; Wang J
J Biol Regul Homeost Agents; 2019 Mar-Apr,; 33(2):563-569. PubMed ID: 30916513
[TBL] [Abstract][Full Text] [Related]
22. Primary salivary duct carcinoma of the lung, mucin-rich variant.
Fishbein GA; Grimes BS; Xian RR; Lee JM; Barjaktarevic I; Xu H
Hum Pathol; 2016 Jan; 47(1):150-6. PubMed ID: 26527521
[TBL] [Abstract][Full Text] [Related]
23. Mucin expression in pleomorphic adenoma of salivary gland: a potential role for MUC1 as a marker to predict recurrence.
Hamada T; Matsukita S; Goto M; Kitajima S; Batra SK; Irimura T; Sueyoshi K; Sugihara K; Yonezawa S
J Clin Pathol; 2004 Aug; 57(8):813-21. PubMed ID: 15280401
[TBL] [Abstract][Full Text] [Related]
24. Prognostic impact of MUC1 and potential regulatory miR-145 and miR-21 expression in salivary mucoepidermoid carcinoma.
Abdolrahmani A; Kardouni Khoozestani N; Azmoudeh-Ardalan F; Shamshiri AR
Head Neck Pathol; 2022 Dec; 16(4):1134-1145. PubMed ID: 35980523
[TBL] [Abstract][Full Text] [Related]
25. MUC1 and MUC5AC mucin expression in liver fluke-associated intrahepatic cholangiocarcinoma.
Boonla C; Sripa B; Thuwajit P; Cha-On U; Puapairoj A; Miwa M; Wongkham S
World J Gastroenterol; 2005 Aug; 11(32):4939-46. PubMed ID: 16124042
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical study of the association between the progression of pancreatic ductal lesions and the expression of MUC1, MUC2, MUC5AC, and E-cadherin.
Kigure S
Rinsho Byori; 2006 May; 54(5):447-52. PubMed ID: 16789413
[TBL] [Abstract][Full Text] [Related]
27. An immunohistochemical panel for reliable differentiation of salivary duct carcinoma and mucoepidermoid carcinoma.
Butler RT; Spector ME; Thomas D; McDaniel AS; McHugh JB
Head Neck Pathol; 2014 Jun; 8(2):133-40. PubMed ID: 24065449
[TBL] [Abstract][Full Text] [Related]
28. Unique expression of MUC3, MUC5AC and cytokeratins in salivary gland carcinomas.
Lee JH; Lee JH; Kim A; Kim I; Chae YS
Pathol Int; 2005 Jul; 55(7):386-90. PubMed ID: 15982212
[TBL] [Abstract][Full Text] [Related]
29. Primary mucoepidermoid carcinoma of the breast: a case report with immunohistochemical analysis and comparison with salivary gland mucoepidermoid carcinomas.
Palermo MH; Pinto MB; Zanetti JS; Ribeiro-Silva A
Pol J Pathol; 2013 Oct; 64(3):210-5. PubMed ID: 24166608
[TBL] [Abstract][Full Text] [Related]
30. Significance of mucin expression in pancreatobiliary neoplasms.
Yonezawa S; Higashi M; Yamada N; Yokoyama S; Goto M
J Hepatobiliary Pancreat Sci; 2010 Mar; 17(2):108-24. PubMed ID: 19787286
[TBL] [Abstract][Full Text] [Related]
31. Expression of mucin antigens in human cancers and its relationship with malignancy potential.
Yonezawa S; Sato E
Pathol Int; 1997 Dec; 47(12):813-30. PubMed ID: 9503463
[TBL] [Abstract][Full Text] [Related]
32. Low-grade salivary duct carcinoma of the parotid gland: report of a case with immunohistochemical analysis.
Kusafuka K; Itoh H; Sugiyama C; Nakajima T
Med Mol Morphol; 2010 Sep; 43(3):178-84. PubMed ID: 20857268
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in mucin immunohistochemistry in salivary gland tumors and head and neck squamous cell carcinoma.
Mahomed F
Oral Oncol; 2011 Sep; 47(9):797-803. PubMed ID: 21723776
[TBL] [Abstract][Full Text] [Related]
34. Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis.
Dharmaraj N; Chapela PJ; Morgado M; Hawkins SM; Lessey BA; Young SL; Carson DD
Hum Reprod; 2014 Aug; 29(8):1730-8. PubMed ID: 24939955
[TBL] [Abstract][Full Text] [Related]
35. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.
Gilbert MR; Sharma A; Schmitt NC; Johnson JT; Ferris RL; Duvvuri U; Kim S
JAMA Otolaryngol Head Neck Surg; 2016 May; 142(5):489-95. PubMed ID: 26939990
[TBL] [Abstract][Full Text] [Related]
36. Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance.
Zhang HK; Zhang QM; Zhao TH; Li YY; Yi YF
World J Gastroenterol; 2004 Oct; 10(20):3044-7. PubMed ID: 15378790
[TBL] [Abstract][Full Text] [Related]
37. Expression and localisation of MUC1 modified with sialylated core-2 O-glycans in mucoepidermoid carcinoma.
Sugiura T; Hashimoto K; Kikuta K; Anazawa U; Nomura T; Kameyama A
Sci Rep; 2023 Apr; 13(1):5752. PubMed ID: 37031283
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of mucin genes in mammary and extramammary Paget's disease.
Kuan SF; Montag AG; Hart J; Krausz T; Recant W
Am J Surg Pathol; 2001 Dec; 25(12):1469-77. PubMed ID: 11717535
[TBL] [Abstract][Full Text] [Related]
39. Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact.
Park SY; Roh SJ; Kim YN; Kim SZ; Park HS; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS
Oncol Rep; 2009 Sep; 22(3):649-57. PubMed ID: 19639217
[TBL] [Abstract][Full Text] [Related]
40. Associations between the expression of mucins (MUC1, MUC2, MUC5AC and MUC6) and clinicopathologic parameters of human breast carcinomas.
Oral O; Unverdi H; Kumcu E; Turkbey D; Dogan S; Hucumenoglu S
Indian J Pathol Microbiol; 2020; 63(4):551-558. PubMed ID: 33154304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
